#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Related Keywords

,Minute Medicine Inc ,Infants ,Nirsevimab ,Respiratory Syncytial Virus Rsv ,Rsv ,Rsv Associated Lower Respiratory Tract Infections ,Studygraphics ,